Explore more publications!
Healthy Living Maldives
Got News to Share?

Healthy Living Maldives: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthy Living Maldives.

September 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30

October 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31

November 2025

Mo Tu We Th Fr Sa Su
1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30

Press releases published on September 24, 2025

Ultrack Systems Inc. (OTC: MJLB) Subsidiary Better Pets Secures Canadian Trademark Registration and Advances U.S. Trademark Application
September 24, 2025

Ultrack Systems Inc. (OTC: MJLB) Subsidiary Better Pets Secures Canadian Trademark Registration and Advances U.S. Trademark Application

Indeterminate GlobeNewswire
Akari Therapeutics’ Preclinical Data Demonstrates the Potential of its Novel ADC Spliceosome Modulating Payload, PH1
September 24, 2025

Akari Therapeutics’ Preclinical Data Demonstrates the Potential of its Novel ADC Spliceosome Modulating Payload, PH1

Indeterminate GlobeNewswire
OneMedNet Expands Into $1.5B Healthcare Data Annotation Market With MedCase
September 24, 2025

OneMedNet Expands Into $1.5B Healthcare Data Annotation Market With MedCase

Indeterminate GlobeNewswire
Sparrow Pharmaceuticals Announces $95 Million Series B Financing to Advance Targeted Therapy for Type 2 Diabetes
September 24, 2025

Sparrow Pharmaceuticals Announces $95 Million Series B Financing to Advance Targeted Therapy for Type 2 Diabetes

Indeterminate GlobeNewswire
Sapu Nano’s Sapu003 Advances to Human Clinical Testing - Transforming Everolimus Delivery with Full Bioavailability for Breast Cancer Patients
September 24, 2025

Sapu Nano’s Sapu003 Advances to Human Clinical Testing - Transforming Everolimus Delivery with Full Bioavailability for Breast Cancer Patients

Indeterminate GlobeNewswire
Tiziana Life Sciences Announces Poster Presentation on Intranasal Foralumab Clinical Trial at the 41st ECTRIMS Congress
September 24, 2025

Tiziana Life Sciences Announces Poster Presentation on Intranasal Foralumab Clinical Trial at the 41st ECTRIMS Congress

Indeterminate GlobeNewswire
Cellectar and Evestia Clinical Announce Partnership to Support Auger-Emitting Radiopharmaceutical Clinical Trial in Triple-Negative Breast Cancer (TNBC)
September 24, 2025

Cellectar and Evestia Clinical Announce Partnership to Support Auger-Emitting Radiopharmaceutical Clinical Trial in Triple-Negative Breast Cancer (TNBC)

Indeterminate GlobeNewswire
Er-Kim Enters Commercialization Agreement with Sentynl Therapeutics for Nulibry® (fosdenopterin) and Zokinvy® (lonafarnib), Targeting Ultra-Rare Diseases
September 24, 2025

Er-Kim Enters Commercialization Agreement with Sentynl Therapeutics for Nulibry® (fosdenopterin) and Zokinvy® (lonafarnib), Targeting Ultra-Rare Diseases

Indeterminate GlobeNewswire
Leading CDMO Enhances cGMP Lab Infrastructure to Strengthen Position
September 24, 2025

Leading CDMO Enhances cGMP Lab Infrastructure to Strengthen Position

Indeterminate GlobeNewswire
EGI Launches Next-Generation HD-EEG Platform to Advance Understanding of Brain Function and Stimulation
September 24, 2025

EGI Launches Next-Generation HD-EEG Platform to Advance Understanding of Brain Function and Stimulation

Indeterminate GlobeNewswire
HealthChannels Reveals Family of Brands to Bring Point-of-Care Solutions to the Most Pressing Secular Challenges in Healthcare
September 24, 2025

HealthChannels Reveals Family of Brands to Bring Point-of-Care Solutions to the Most Pressing Secular Challenges in Healthcare

Indeterminate GlobeNewswire
NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Receives Notification of US Food and Drug Administration Approval of Suitability Petition for NRx’s Proposed Strength of Preservative-Free Ketamine
September 24, 2025

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Receives Notification of US Food and Drug Administration Approval of Suitability Petition for NRx’s Proposed Strength of Preservative-Free Ketamine

Indeterminate GlobeNewswire
MAIA Biotechnology Awarded $2.3 Million Grant by National Institutes of Health for THIO-101 Phase 2 Trial of Cancer-Fighting Agent
September 24, 2025

MAIA Biotechnology Awarded $2.3 Million Grant by National Institutes of Health for THIO-101 Phase 2 Trial of Cancer-Fighting Agent

Indeterminate GlobeNewswire
Aging in Place, Limited Access to Medical Care and Economic Insecurity Threaten U.S. Senior Health
September 24, 2025

Aging in Place, Limited Access to Medical Care and Economic Insecurity Threaten U.S. Senior Health

Indeterminate GlobeNewswire
BPGbio Sponsors MitoAction Energy Walk at Boston’s Franklin Park Zoo on September 27th, 2025
September 24, 2025

BPGbio Sponsors MitoAction Energy Walk at Boston’s Franklin Park Zoo on September 27th, 2025

Indeterminate GlobeNewswire
Daré Bioscience to Receive up to $499,000 to Support Preeclampsia Research
September 24, 2025

Daré Bioscience to Receive up to $499,000 to Support Preeclampsia Research

Indeterminate GlobeNewswire
NewAmsterdam Pharma to Present at the Stifel 2025 Virtual Cardiometabolic Forum
September 24, 2025

NewAmsterdam Pharma to Present at the Stifel 2025 Virtual Cardiometabolic Forum

Indeterminate GlobeNewswire
Proscia to Expand Pathology AI Capabilities with Virtual Staining
September 24, 2025

Proscia to Expand Pathology AI Capabilities with Virtual Staining

Indeterminate GlobeNewswire
Kura Oncology to Participate in Upcoming Investor Conference
September 24, 2025

Kura Oncology to Participate in Upcoming Investor Conference

Indeterminate GlobeNewswire
LEQEMBI® (Lecanemab) Approved for the Treatment of Alzheimer’s Disease in Australia
September 24, 2025

LEQEMBI® (Lecanemab) Approved for the Treatment of Alzheimer’s Disease in Australia

Indeterminate GlobeNewswire
Show More

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions